All In MedTech

PMA device

Amplatzer Amulet LAA Occluder

Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

1

PMA pathway

Device trials

6

Naming "Amplatzer Amulet LAA"

MAUDE reports

2

Brand "Amplatzer Amulet LAA", since 2015

PubMed studies

15

Mentioning "Amplatzer Amulet LAA"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing Amplatzer Amulet LAA Occluder

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 1 of 1 decisions filed under this name.

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

Clinical trials

Device studies on ClinicalTrials.gov that name "Amplatzer Amulet LAA", any status and sponsor, newest update first.

Open in Trial Radar
  • Abbott Medical DevicesPublic (ABT)

    NCT06189365 · 50 participants · Start Jan 30, 2024 · Primary completion Dec 5, 2025

    Device: Left Atrial Appendage (LAA) closure procedure with Amplatzer Amulet LAA occluder · For: Non-Valvular Atrial Fibrillation

    Sites: Shenzhen, China; Wuhan, China; Changsha, China · 5 sites in all

  • Chinese University of Hong KongAcademic, hospital or other

    NCT07483008 · 184 participants · Start Oct 1, 2017 · Primary completion Jan 31, 2022

    Device: 3D-printed models of the left atrial appendage · For: Atrial Fibrillation (AF); 3D Printing; Cost Benefit Analysis

    Sites: Hong Kong, Hong Kong

  • Amplatzer Amulet LAAO vs. NOACPivotal-lookingActive, not recruiting

    Abbott Medical DevicesPublic (ABT)

    NCT04226547 · 2,650 participants (planned) · Start Jul 7, 2020 · Primary completion Jan 2029

    Device: Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder) · For: Atrial Fibrillation; Stroke; Bleeding

    Sites: Birmingham, Alabama; Huntsville, Alabama; Phoenix, Arizona · 127 sites in all

3 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "Amplatzer Amulet LAA", and for the whole product code for context.

This brand

2 reports: 0 malfunction, 2 injury, 0 death

Whole product code NGV

17,771 reports: 1,912 malfunction, 13,990 injury, 1,862 death

Newest reports for this brand

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

Published research

The most relevant PubMed records for "Amplatzer Amulet LAA"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

Other devices of this type

Also filed under product code NGV.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.